Novo Nordisk Inc., a leading global healthcare company, is headquartered in the United States and operates extensively across North America and beyond. Founded in 1923, Novo Nordisk has established itself as a pioneer in diabetes care, producing innovative insulin products and devices that cater to the needs of millions worldwide. The company is also a key player in the fields of obesity care, haemophilia, and growth hormone therapy, offering unique solutions that enhance patient outcomes. With a strong commitment to sustainability and research, Novo Nordisk has achieved significant milestones, including advancements in diabetes management technologies. Recognised for its market leadership, Novo Nordisk continues to set industry standards, driven by a mission to improve the lives of people with chronic conditions.
We don't have data for Novo Nordisk Inc., but we can show you information about their parent organization instead.
View parent company